Blended Interferon-Alpha and Interleukin-2 Therapy from United States
A mixed preparation of recombinant interferon-alpha and interleukin-2 for treating viral infections and boosting immune response in immunotherapy. It is a mixed immunological product (interferons and interleukins) not in retail sale, so it is classified under tariff item 3002.14.00.
Duty Rate — United States → Canada
0%
Import Tips
• Confirm the product is in bulk and not in measured doses or retail packs
• Keep documentation of the recombinant origin and mixing ratios for CBSA
• Ensure compliance with Health Canada regulations for biological drugs